Iradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $17 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.